4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-055172
EVP, Finance sold 375 shares at $87.99 ($32,996)
From the SEC's structured data for this filing
Trades in this filing
Sharp Shalini · EVP, Finance
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-14 | Sale : show line 1 in the form | −375 | $87.99 | $32,996 | 97,812 | D |
| Open-market sales · 375 sh · avg $87.99 · $32,996 | ||||||
Loading xslF345X03/doc4.xml…